Evidence map›Paper›PMID 36557759›Full record

ArticleMicroorganisms2022

Taghreed A Hafiz, Esraa Aldawood, Alaa Albloshi, Shahad S Alghamdi, Murad A Mubaraki, Ahmed S Alyami, Marwh G Aldriwesh

Abstract read
In one paragraph

Article in Microorganisms, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed.

  1. Distribution and Antibiotic Resistance ofAntibiotics (Basel, Switzerland) · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Insights into antibiotic resistance and prevalence ofNew microbes and new infections · 2025
    Review
  7. Article
  8. Genetic Diversity ofPathogens (Basel, Switzerland) · 2025
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Review
  17. Article
  18. First Report ofLife (Basel, Switzerland) · 2023
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Taghreed A HafizClinical Laboratory Sciences Department, College of Applied Medical Sciences, King Saud University, Riyadh 12372, Saudi Arabia.ORCID 0000-0001-8594-215X
Esraa AldawoodClinical Laboratory Sciences Department, College of Applied Medical Sciences, King Saud University, Riyadh 12372, Saudi Arabia.
Alaa AlbloshiClinical Laboratory Sciences Department, College of Applied Medical Sciences, King Saud University, Riyadh 12372, Saudi Arabia.ORCID 0000-0002-1052-9739
Shahad S AlghamdiRegional Laboratory and Central Blood Bank, Microbiology Department, Albaha 65715, Saudi Arabia.
Murad A MubarakiClinical Laboratory Sciences Department, College of Applied Medical Sciences, King Saud University, Riyadh 12372, Saudi Arabia.
Ahmed S AlyamiPathology and Clinical Laboratory Medicine, King Fahad Medical City, Riyadh 11525, Saudi Arabia.
Marwh G AldriweshDepartment of Clinical Laboratory Sciences, College of Applied Medical Sciences, King Saud bin Abdulaziz University for Health Sciences, Riyadh 11481, Saudi Arabia.ORCID 0000-0001-6319-2669

Funding

Deputyship for Research & Innovation, Ministry of Education in Saudi Arabia IFKSURG-2-000
6 · The paper itself

Abstract

background

methodsThe study included 393

resultsThe

conclusionsThe identification of

Indexed as

COVID-19ICUMDRnosocomial infectionPDRrespiratoryStenotrophomonas maltophilia

Identifiers

PMID36557759
PMCPMC9786049

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.